Applying Scientific Rigor To Microbiome Therapeutics

PharmaBiome’s Second-Generation Candidates

Tomas de Wouters, one of In Vivo’s 2020 Rising Leaders, has taken on the complex challenge of the microbiome, aiming to design the next generation of microbiome therapeutic candidates targeted at host-microbial interactions. 

Microbiome_Analysis
• Source: Shutterstock

More from Innovation

More from In Vivo